Skip to main content
Log in

Milde symptomatische pulmonal-arterielle Hypertonie

Therapie mit Bosentan?

Mildly symptomatic pulmonary arterial hypertension

Treatment with bosentan?

  • Journal Club
  • Published:
Der Pneumologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Galie N, Ghofrani HA, Torbicki A et al (2005) Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353:2148–2157

    Article  PubMed  CAS  Google Scholar 

  2. Galie N, Olschewski H, Oudiz RJ et al (2008) Ambrisentan for the treatment of pulmonary arterial hypertension. Circulation 117:3010–3019

    Article  PubMed  CAS  Google Scholar 

  3. Rubin LJ, Badesch DB, Barst RJ et al (2002) Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 346:896–903

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist auf folgende Beziehungen hin: Der korrespondierende Autor hat Honorare im Rahmen von Referententätigkeiten von den Firmen Actelion (Hersteller von Bosentan), Bayer-Schering (Hersteller von Iloprost), Encysive (Hersteller von Sitaxentan) und GlaxoSmithKline (Hersteller von Ambrisentan) erhalten.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Halank.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Halank, M. Milde symptomatische pulmonal-arterielle Hypertonie. Pneumologe 6, 35–36 (2009). https://doi.org/10.1007/s10405-008-0273-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10405-008-0273-1

Navigation